Author: Cobo, Fernando
Title: Application of Molecular Diagnostic Techniques for Viral Testing Document date: 2012_11_30
ID: jiy4cp4n_99
Snippet: Molecular techniques can be very useful for the diagnosis of viral hepatitis infections such as hepatitis A, B, C, D and E in cases in which serological assays are no conclusive. However, currently the main application of nucleic acid test in the management of these viruses, above all hepatitis B and C, is the detection of serum or plasma viral load of these viruses for monitoring therapeutic responses of infected patients. Assays to quantify hep.....
Document: Molecular techniques can be very useful for the diagnosis of viral hepatitis infections such as hepatitis A, B, C, D and E in cases in which serological assays are no conclusive. However, currently the main application of nucleic acid test in the management of these viruses, above all hepatitis B and C, is the detection of serum or plasma viral load of these viruses for monitoring therapeutic responses of infected patients. Assays to quantify hepatitis B and C virus load in liver tissue have also been described [83, 84] . HBV DNA detection and HBV DNA viral load are also essential to explore a viral reactivation. Real-time PCR quantification assays are widely used because of their sensitivity, specificity, accuracy, broad dynamic range and positive predictive values. The World Health Organization (WHO) has defined international standards [85] . However, because of these techniques do not use the same HBV primers, follow up of patients should be carried out with the same technical assay in order to compare viral DNA load evolution. With respect to the HBV genotypes, there is currently a need to perform it due to several factors such as the prediction of clinical outcomes and the association with response to interferon treatment [86] . Genotyping of chronic HBV infections can help practicing physicians identify those at risk of disease progression and determine optimal antiviral therapy. Methods to determine the viral genotypes are based on hybridization and sequencing, and genotype affiliation rely on phylogenetic analyses.
Search related documents:
Co phrase search for related documents- antiviral therapy and clinical outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
- antiviral therapy and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
- antiviral therapy and disease progression risk: 1, 2, 3, 4
- antiviral therapy and dna detection: 1, 2, 3
- antiviral therapy and dna load: 1
- antiviral therapy and dynamic range: 1
- antiviral therapy and HBV genotype: 1, 2
- antiviral therapy and HBV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- antiviral therapy and hepatitis infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- antiviral therapy and infected patient: 1, 2, 3, 4, 5, 6, 7, 8
- antiviral therapy and interferon treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- antiviral therapy and liver tissue: 1
- antiviral therapy and nucleic acid test: 1, 2, 3, 4, 5, 6, 7, 8, 9
- antiviral therapy and optimal antiviral therapy: 1, 2, 3, 4
- antiviral therapy and patient follow: 1, 2, 3, 4
- antiviral therapy and PCR quantification: 1, 2
- antiviral therapy and PCR quantification assay: 1
- antiviral therapy and phylogenetic analysis: 1, 2
- antiviral therapy and positive predictive value: 1
Co phrase search for related documents, hyperlinks ordered by date